ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.85
0.00 (0.00%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.85 4.70 5.00 4.95 4.85 4.95 383,710 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -11.55 25.87M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.85p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £25.87 million. Eden Research has a price to earnings ratio (PE ratio) of -11.55.

Eden Research Share Discussion Threads

Showing 7326 to 7346 of 17800 messages
Chat Pages: Latest  304  303  302  301  300  299  298  297  296  295  294  293  Older
DateSubjectAuthorDiscuss
27/9/2019
17:33
Ken, good to see you here. Agreed re revenues; though there may be something in Sustaine to put a bomb up the share price. Sooner or later the discussions will need to conclude.
brucie5
27/9/2019
16:38
If Cenkos were to come up with an incredibly bullish note and with, say, a £2 price target for Eden it probably wouldn't help the share price.

Increasing revenues and profits would do the trick.

kenmitch
27/9/2019
16:16
Maybe a lot of PIs use Stockopedia (or similar) these days. Doesn't Eden have a poor rating on that?
weyweyumfozo
27/9/2019
15:22
Never delivering on time and total contempt for shareholders/owners but they are ok at tweeting to the 200 people that follow us..... asteroid jam tomorrow...
bjlk
27/9/2019
13:21
On the 8th of July via RNS Eden research made the following statement

"Appointment of Nominated Adviser and Broker

Eden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries, today announces that it has appointed Cenkos Securities plc as sole broker and Nominated Adviser with immediate effect."

Subsequently, Cenkos has distributed a detailed 50+ page research note on Eden titled 'Killing It'

As we stand this very day, Eden's share price is backtracking further, 26p in 2014 to mid 8's 5 years later valuing the company at around £16+million.

Cenkos appears not to have the ability to drive anyone into the share price and if Cenkos has a discretionary fund, they have not used it.

So the question is 'why is Eden not killing it?

And why is Eden not doing anything about it?

Any why is no one buying Eden stock?

Has Eden even analysed the why?

Is Eden even concerned about the why?

Is the Eden prospect truly understood?

Eden Management having made the change from Shore Capital to Cenkos should be in the offices of Cenkos right now asking them what the hell is going on?

What remit has Eden given Cenkos?

What efforts has Cenkos made, in what channels and with what outcomes?

What are the next steps in Cenkos play to get the share price closer to the 'killing it' statement?

Has Cenkos been provided the ammunition and latitude to so?


WHY IS EDEN'S SHARE PRICE FAILING SO DISMALLY AND WHEN ARE SHAREHOLDERS, CERTAINLY THE LARGEST ONES, GOING TO CALL MANAGEMENT TO ACCOUNT?

investingisatrickygame
27/9/2019
12:41
Albatross, I can't recall having one, though you may be able to dig one up. I think projections for the time being, is for the birds, and for Jak, of course.

For time being I think Cenkos has it about right. But where Jak never wants to stray is into the reality of CED/MEV and the sheer time it's taken to get these to where they are now. With each new territory and application the value of those two will become increasingly evident. And that of course is a function of Sipcam and Eastman, whose longer term interests will of course be well in excess of the current suggested value! Sipcam, need we remind ourselves, is already a strategic investor in the company.

brucie5
27/9/2019
10:14
Brucie
If it's not too much trouble would you please remind us what our end of year share price guesstimates were for your competition. (Or would it be too depressing?)

littlealbatross2
27/9/2019
09:57
Northwick, it's a waiting game now, I'm afraid. But current markets mean that you're not exactly spoiled for choice for alternative place to put your cash - except in cash!

Hopefully, the EPA regulatory permissions for MEV/CED will come this side of Christmas as put some more 'terra firma' underneath that combined $1.2bn market opportunity. According to my working, last years sales at £1.6m was c. 1% of that - on far smaller slice of the available universe.

brucie5
27/9/2019
08:19
Surely, someone out there must be interested in Eden, and in its potential?
northwick
25/9/2019
14:23
Tumbleweed.
bjlk
24/9/2019
12:10
FYI.. SEE on the move ..

Here is why;

supersonico
24/9/2019
11:45
Thomas Cook V Eden

How timely. I see Thomas Cook is being hammered in the paper today and on the radio. One of the central issues is the unsustainable pay and options of the directors which when the options did not work out vis-à-vis price, were just 're-worked' to enable that function to transpire.

The issue being debated is why have the directors been awarded so much pay AND options when the share price has done nothing over 10 years and the first requirement of a Plc is to 'manage its share price' I kid you not, it has been on radio 5 live today and this is the 'professional' argument.

Thomas Cook was a loss making operation, their share price travelled backwards and the directors continued to reward themselves handsomely.

Eden is a loss making operation, our share price is going backwards and the directors courtesy of the remuneration committee continue to pay extremely healthy salaries, very generous bonuses and options, albeit the latter is failing.

Now, none of this is personal for me and the directors read these boards and can see mine and others written words. But I believe I am posting facts!!!!!

Why don't Eden set an example, cut back the pay, bonuses and share option awards or set the latter to kick in at 30p/50/70p, show understanding, show a sign of intent to the market and then understandably, take their rewards, when they have earned them and their co-owners have too via the share price.

That sounds fair and sustainable to me and equally, GRAS for the cash burn. One might argue, 'The Natural Solution!'

investingisatrickygame
24/9/2019
08:12
Brilliant...well reasoned and absolutely true...
bjlk
24/9/2019
07:25
EDEN SHARE OPTIONS

I think the directors of Eden have now missed out on several options put in place, but not achieved. Maybe someone would care to detail them here. The most recent ones lapsed on the 30th September 2019.

Is this important? Well, I think it is. Eden has been a small group of 2 + 2 being the principle directors and then the remuneration committee made up of other directors. They obviously felt as a collective that the price set to enable the options to become valid were reasonable targets, but evidence shows that either
a) the price set was unreasonable,
b) that markets and economies went against Eden,
c) that management failed to fulfil on internal deliverables to justify such a price or
d) that management failed to communicate the forward proposition for the Company to stimulate and drive value in the company

Well is doesn't look like a to me and it is most certainly not b which will take us to c and to d. We might even be able to eliminate c when we look at the bonuses management has been taking this last few years which would seem to indicate that they have delivered internally and as such have been rewarded very handsomely.

So it would have to be d, that management failed to communicate the forward proposition for the Company to stimulate and drive value in the company

They even bought shares themselves around 14p and here we are at 9p. So clearly they felt at the time of purchase that 14p was a good entry point, they probably still do. But I bet they are kicking themselves mentally about that now with the price down over 30%. Bad judgement or bad luck. Well the world has not gone against Eden do bad judgement.

Eden needs to understand that they have to get on the front foot and in a way that is not 'pumping' the shares, a fear I believe they may have previously held.

Communicate to the investment community with enthusiasm and positivity

1) Why Eden is one of a few differentiators and explain that properly so it is truly understood
2) Talk about the principle markets for Eden, their market value at a European and global level and then communicate what might be a reasonable target % for Eden's products to achieve in 1,2 & 3 years, with the assistance of their distributors. So, paint the picture and show the reasonable possibility
3) Break down what that would look like in revenue terms under the current model and how that would extrapolate
4) Of all of those patents applied for and pending, talk about what is live and in play this next 3 years, what markets, market sizes and the perceived realistic opportunity and Eden delivering a commercial product for those markets, naturally subject to field tests and regulatory approval
5) Explain the regulatory system, not as a negative barrier, in the hands of others, we have no control (yawn, everyone goes through the same process). Accept the process, see yourselves not as hindered by time, but talk about once regulatory approval is gained which is short in time vis-à-vis the lifetime revenue of an approved product, why you are on the cusp of significant change for the Company e.g. G3Y $2.8 billion a year global market

Eden needs to paint a window of opportunity, not a picture of restraint.

Eden needs to show why money invested today is so worthwhile, not dead money, but money invested into a market of growing trends, favourable trends and that Eden is in the right place at the right time.

Why is this so difficult for Eden to execute? £250,00-£;350,000 Executives cannot find the time to structure something so worthwhile and an extremely important part of their working day. So saying you are resource and time short is in my opinion, a misunderstood measure of your day and of the value and role of your share price as a Plc.

investingisatrickygame
22/9/2019
16:42
I'd stop now if I was Fraudy..it's going to get very embarrassing because when Lykele said in the Half Yearly Report,

"Additionally, Eden has a number of exciting product developments underway internally, and with various commercial partners, which should see the Company build into a global player in the biopesticides industry in the medium term."

He meant it.

supersonico
22/9/2019
13:03
Fraudy Lube In Summary..

If I believed what I'm saying their would be more Lube as all serious Lube campaigns involve multiple choreographed narrative building Lube characters.

This is not a serious campaign.

Come on Fraudy Man-up.

#LonelyLube# Cedroz

supersonico
22/9/2019
11:22
Eden in summary

R & D product X how many years

Field trials X two seasons/years

Regulatory approval X one year or up to

Product sales and conversion/adoption X 2 years plus to gain trust and penetrate the market

Possibly 5 years from field trials to meaningful revenue (when a product is not seasonally affected, like Mevalone, otherwise longer).


Eden's share price 26p to 9p in 5 years when Eden HAS successfully gone through the above, so -60%

We are told G3Y is entering the end (I believe) of season 2 trials, so maybe another 3 years before any meaningful revenue.

Cedroz is known about, is a replacement product for Eastman and so should grab, hopefully, a natural market share. Regulatory approval is not yet secured, so maybe 2-3 years away.

Brokers consistently WILL NOT factor in the next 3 years anticipated income for Eden.

QUESTIONS

What is it that management expects will drive the share price given the above?

What is it that shareholders think will drive the share price given the above?


Artemis has been a seller for a while as evidenced by the share register. When that overhang is gone, will the price rise a little or will another seller materialise?

Even if the sellers are removed and the price rises, what is the first price point for exasperated shareholders to exit? Has Eden and its advisers planned for this? If so how? Who will step in again and mop up the sellers at that point?

Eden in my opinion has an ongoing overhang whereby shareholders will sell into any rise that occurs because faith, time and more has them longing to remove themselves from the dire situation of the Eden share price.


There are plenty of regulatory environments where share prices fly beforehand.

Eden doesn't require huge capital to get of the ground, yet huge capital projects that do, still see there share price flying, knowing that is ahead of them, but because the asset base has risen.

Eden excuses around regulatory environments doesn't hold water. It is wrong of them to say so and to say that shareholders don't understand when I'm sure that they do.

Eden assets, in part, are its IP. 110 granted and pending patents we are told, but no value seems to be apportioned to these assets. Could that be because of the suggested timelines above?

Personally, I feel that Eden makes too many excuses on third parties and process as their excuse for the share price and doesn't put enough emphasis on the forward value of the business and the solutions they deliver to the crop protection market which are much needed. their story is one of excuses and negativity, not one of reasons to invest and positivity. They do not open up the investment communities eyes to what they believe they will deliver.

And, their emphasis continues to be institutions when Eden has a declining share price making Eden even less attractive and less able to invest in (Mcap). The resulting effect as we see is no demand for the company's shares, no belief in management as evidenced by the lack of buying and a flight elsewhere to greater visibility, expectation and potential reward.

investingisatrickygame
22/9/2019
08:23
120 Cedroz emergency days have come and Gone.
supersonico
21/9/2019
20:17
Have those 20 questions left them scratching their heads... oh wait a cure is coming!! Asteroid jam tomorrow..
bjlk
21/9/2019
19:42
20 questions?

Will the share price ever go up ?

Will the board bask in the glory of the Agrow awards coming up .

Will they choose the vegan option from the menu?

Will the BOD finish their Open University course on Science and the environment?

Will they then go on to do a 5yr course on Business for small companies?

Will they diversify into business for Italian lab technicians.

Will they diversify into Chinese law to protect their sales.

Will they go into robotics to spend less time in the warm office writing pesky reports?

Will they buy up a private company with the money they’ve saved from their salaries?


Will they buy a junior science kit to start researching ?

Will they start putting by a little for a rainy day ; they can buy a sprayer for Mevalone?

Will they discover...... a grower when they are out with their distributors?

Will they buy some wellies and disposable white coveralls ,rubber gloves anti septic wipes to really get out there and ......

Will they buy a blackboard eraser for the forthcoming office reports ?

Will they take on a currency dealer for helping with their salaries post Brexit?

Will the Daily Telegraph start a new Cartoon strip called Alex.

Will the new cartoon have everyone falling over with laughter and buying into his masterly guidance?

chrischas
20/9/2019
17:36
hxxp://www.worldstopexports.com/coffee-exports-country/
investingisatrickygame
Chat Pages: Latest  304  303  302  301  300  299  298  297  296  295  294  293  Older

Your Recent History

Delayed Upgrade Clock